Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression sustained improvement in kidney ...

Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...

Rapid advances in sequencing technologies have transformed our ability to diagnose human genetic disorders, yet many patients still lack a molecular ...

Environmental and chemical exposures have emerged as critical contributors to the global cancer burden. Sources such as dietary contaminants, food ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...

A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, potentially reshaping how these treatments are produced.

The chip can simulate breathing and lung disease for an individual, holding promise for testing personalized treatments for tuberculosis.

Trethera Corp. received a $2.7M NIH grant to study combining TRE-515 with KRAS inhibitors for lung cancer. Learn how this ...